GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » PB Ratio

CTOR (Citius Oncology) PB Ratio : 1.04 (As of Apr. 12, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-12), Citius Oncology's share price is $0.6714. Citius Oncology's Book Value per Share for the quarter that ended in Sep. 2024 was $0.65. Hence, Citius Oncology's PB Ratio of today is 1.04.

The historical rank and industry rank for Citius Oncology's PB Ratio or its related term are showing as below:

CTOR' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.04
Current: 1.04

During the past 3 years, Citius Oncology's highest PB Ratio was 1.04. The lowest was 0.00. And the median was 0.00.

CTOR's PB Ratio is ranked better than
78.29% of 935 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs CTOR: 1.04

During the past 12 months, Citius Oncology's average Book Value Per Share Growth Rate was 80.20% per year.

Back to Basics: PB Ratio


Citius Oncology PB Ratio Historical Data

The historical data trend for Citius Oncology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology PB Ratio Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24
PB Ratio
- - 2.16

Citius Oncology Semi-Annual Data
Sep22 Sep23 Sep24
PB Ratio - - 2.16

Competitive Comparison of Citius Oncology's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Citius Oncology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Citius Oncology's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citius Oncology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Citius Oncology's PB Ratio falls into.


;
;

Citius Oncology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Citius Oncology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=0.6714/0.645
=1.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Citius Oncology  (NAS:CTOR) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Citius Oncology PB Ratio Related Terms

Thank you for viewing the detailed overview of Citius Oncology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Citius Oncology Business Description

Traded in Other Exchanges
N/A
Address
11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.